The race for practical quantum advantage has entered a new phase as PsiQuantum begins construction on its massive facility in Moreton Bay, Queensland. The company aims to build the world's first utility-scale, fault-tolerant quantum computer, moving beyond current experimental limitations to create a system capable of solving real-world commercial problems.
The Photonic Advantage
Unlike the superconducting qubits used by IBM and Google, PsiQuantum leverages a photonic approach. By using particles of light routed through silicon chips manufactured in standard semiconductor foundries, the company believes it can scale more efficiently. The Moreton Bay site is designed to house tens of thousands of these photonic chips, interconnected via standard optical fiber.
A critical component of the facility is its cooling infrastructure. As detailed by TNW Neural, the site will feature one of the largest cryogenic systems ever built for quantum computing, with a massive cryoplant from Linde Engineering scheduled for delivery in late 2027.
Massive Capital Influx
The project is backed by a combination of sovereign wealth and private venture capital. The Australian federal and Queensland governments have committed A$940 million (approx. $620 million USD). Additionally, the US Department of Commerce provided a $100 million letter of intent under the CHIPS and Science Act, highlighting the strategic importance of the technology.
Private investment has been equally aggressive. A $1 billion Series E round closed in September 2025, led by BlackRock and Temasek with participation from Nvidia's venture arm, valuing PsiQuantum at $7 billion.
The Road to One Million Qubits
PsiQuantum's ultimate goal is a system featuring approximately one million qubits. While no company has yet achieved commercial-scale fault tolerance, the photonic path is seen as a shortcut to this milestone. The company has already established a Test and Validation Lab at Griffith University to refine the subsystems before they are integrated into the Moreton Bay machine, targeting breakthroughs in materials science, drug discovery, and complex logistics.

No comments yet. Be the first!